Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 March 1998

Different methods of 20% Mannitol administration on early diuresis in kidney graft recipients

Cezary Pakulski, Andrzej Świniarski

Med Sci Monit 1998; 4(2): CR268-271 :: ID: 502600

Abstract

Introduction: The aim of this study was to investigate the different methods of 20% Mannitol administration on the occurrence of early diuresis in kidney graft recipients as well as on long-term kidney transplantation results. Early diuresis was defined as diuresis that exceeded the patient's own kidneys excretory function of 30 ml/kg b.m before the graft transplantation. Methods: 42 patients (21 pairs) - kidney graft recipients in 1994 - were included in the study. Each patient from a given pair received one kidney from the same donor. Both recipients from each pair were randomly included in one of the two groups. An appropriate volume of Mannitol was administered before kidney reperfusion in group I, and in group II Mannitol was administered following graft reperfusion. 20% Mannitol was administered at a dose of 0.7 g/kg b. m. with a rate infusion of 10 ml/min. Renal excretory function was evaluated in the first and second postoperative days as well as 1 month and 1 year after renal transplantation. Results: On the 1st postoperative day early diuresis occurred in 16 patients (76%) from group I and in 12 patients (57%) from group II. On the 2nd postoperative day early diuresis occurred in 62% and 48% of patients, respectively. Early diuresis had been followed by a significant decrease in the serum creatinine level. Satisfactory graft function had been found in 95% of patients from group I and in 100% of patients from group II following 30 days after renal transplantation. The one-year graft survival rate was 86% in both groups. Conclusion: Early 20% Mannitol administration significantly increases the chance for early diuresis, but has no influence on short and long-term renal transplantation results.

Keywords: renal transplantation, 20% Mannitol, early diuresis

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750